ScholarIQanswers from OpenAlex & ORCID
Yen‐Fu Chen
ResearcherPublications, citations & collaboration network
Yen‐Fu Chen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yen‐Fu Chen have?
ScholarIQindexed works
Yen‐Fu Chen has 377 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yen‐Fu Chen have?
ScholarIQcitation count
Yen‐Fu Chen has 9,124 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yen‐Fu Chen?
ScholarIQh-index
Yen‐Fu Chen has an h-index of 46 in OpenAlex.
What is the i10-index of Yen‐Fu Chen?
ScholarIQi10-index
Yen‐Fu Chen has an i10-index of 125 in OpenAlex.
What is the ORCID of Yen‐Fu Chen?
ScholarIQorcid
The ORCID for Yen‐Fu Chen is on the source record.
What is the OpenAlex record for Yen‐Fu Chen?
ScholarIQopenalex
The OpenAlex for Yen‐Fu Chen is on the source record.
What are the most-cited papers on Yen‐Fu Chen?
ScholarIQmost cited works
The systemic immune response to trauma: an overview of pathophysiology and treatment
Janet M. Lord, Mark J. Midwinter, Yen‐Fu Chen, Antonio Belli, Karim Brohi, Elizabeth J. Kovacs, Leo Koenderman, Paul Kubes, Richard Lilford
The history, geography, and sociology of slums and the health problems of people who live in slums
Alex Ezeh, Oyinlola Oyebode, David Satterthwaite, Yen‐Fu Chen, Robert Ndugwa, Jo Sartori, Blessing Mberu, G. J. Meléndez‐Torres, Tilahun Haregu, Sam Watson, Waleska Teixeira Caiaffa, Anthony Capon, Richard Lilford
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Kai‐Cheng Hsu, Yen‐Fu Chen, Shen-Rong Lin, Jinn‐Moon Yang
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements
Syed Ahsanuddin Ahmed, Motunrayo Ajisola, Kehkashan Azeem, Pauline Bakibinga, Yen‐Fu Chen, Nazratun Nayeem Choudhury, Olufunke Fayehun, Frances Griffiths, Bronwyn Harris, Peter Kibe, Richard Lilford, Akinyinka Omigbodun, Narjis Rizvi, Jo Sartori, Simon Smith, Sam Watson, Ria Wilson, Godwin Yeboah, Navneet Aujla, Iqbal Azam, Peter J. Diggle, Paramjit Gill, Romaina Iqbal, Caroline Kabaria, Lyagamula Kisia, Catherine Kyobutungi, Jason Madan, Blessing Mberu, Shukri F. Mohamed, Ahsana Nazish, Oladoyin Odubanjo, Mary E. Osuh, Eme Owoaje, Oyinlola Oyebode, João Porto de Albuquerque, Omar Rahman, Komal Tabani, Olalekan John Taiwo, Grant Tregonning, Olalekan A. Uthman, Rita Yusuf
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Yen‐Fu Chen, Paresh Jobanputra, Pelham Barton, Sara E. Bryan, A Fry-Smith, Gerald J. Harris, Robert Taylor